Troglitazone
- Generic Name
- Troglitazone
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C24H27NO5S
- CAS Number
- 97322-87-7
- Unique Ingredient Identifier
- I66ZZ0ZN0E
- Background
Troglitazone was withdrawn in 2000 due to risk of hepatotoxicity. It was superseded by pioglitazone and rosiglitazone.
- Indication
For the treatment of Type II diabetes mellitus. It is used alone or in combination with a sulfonylurea, metformin, or insulin as an adjunct to diet and exercise.
- Associated Conditions
- -
- Associated Therapies
- -
No news found
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath